The gastrointestinal system and our daily lives are impacted by oxidative stress, ageing, diet, lifestyle, alcohol, trauma, prolonged stress, surgery, nutrient deficiencies, drug use, excessive exercise, starvation, infection, inflammation, hygiene and socioeconomic conditions.
The human detoxification system is a delicate and complex process involving three distinct phases. However, it is only very recently that we have elucidated the function and significance of Phase III. We now understand that any successful therapeutic management of detoxification requires us to restore, manage and augment this phase, which can then have profound implications for health and resilience.
The simple, safe intervention of Chondroitin Sulphate in painful osteoarthritis has just been given a boost in confidence! Showing remarkable efficacy, against the most commonly prescribed medical therapy.
Even though the liver is considered the primary organ of detoxification, the integrity of the intestinal epithelial barrier must not be underestimated. The gastrointestinal tract (GIT) is a major site for dealing with toxic burden. Over the course of a lifetime, the GIT processes more than 25 tonnes of food, which represents the largest load of antigens and toxins confronting the human body.
Homocysteine is an intermediate produced in the metabolism of sulfur-containing amino acids. Elevated levels of homocysteine are associated with heart attack, heart disease, vascular disease as well as dementia and cognitive decline, macular degeneration, migraine, neural tube defects and bone fractures.
Ubiquinol is a reasonably new supplement now approved by the Therapeutic Goods Administration (TGA) and therefore available to Australian Healthcare Professionals. Prior to its recent addition to the Australian Register of Therapeutic Goods (ARTG) CoQ10 was only available in the form of ubiquinone, both forms, are now marketed as supplemental options for coenzyme Q10.